11-119345521-A-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_031433.4(MFRP):c.540T>C(p.His180His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.948 in 1,613,992 control chromosomes in the GnomAD database, including 725,449 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.92 ( 64584 hom., cov: 32)
Exomes 𝑓: 0.95 ( 660865 hom. )
Consequence
MFRP
NM_031433.4 synonymous
NM_031433.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.25
Publications
31 publications found
Genes affected
MFRP (HGNC:18121): (membrane frizzled-related protein) This gene encodes a member of the frizzled-related protein family. The encoded protein plays an important role in eye development and mutations in this gene have been associated with nanophthalmos, posterior microphthalmia, retinitis pigmentosa, foveoschisis, and optic disc drusen. The protein is encoded by a bicistronic transcript which also encodes C1q and tumor necrosis factor related protein 5 (C1QTNF5). [provided by RefSeq, Jun 2013]
C1QTNF5 (HGNC:14344): (C1q and TNF related 5) This gene encodes a member of a family of proteins that function as components of basement membranes and may play a role in cell adhesion. Mutations in this gene have been associated with late-onset retinal degeneration. The protein may be encoded by either a bicistronic transcript including sequence from the upstream membrane frizzled-related protein gene (MFRP), or by a monocistronic transcript expressed from an internal promoter. [provided by RefSeq, Jun 2013]
C1QTNF5 Gene-Disease associations (from GenCC):
- late-onset retinal degenerationInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BP6
Variant 11-119345521-A-G is Benign according to our data. Variant chr11-119345521-A-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 167297.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.25 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.954 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MFRP | ENST00000619721.6 | c.540T>C | p.His180His | synonymous_variant | Exon 5 of 15 | 1 | NM_031433.4 | ENSP00000481824.1 |
Frequencies
GnomAD3 genomes AF: 0.920 AC: 139959AN: 152098Hom.: 64526 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
139959
AN:
152098
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.932 AC: 231719AN: 248740 AF XY: 0.938 show subpopulations
GnomAD2 exomes
AF:
AC:
231719
AN:
248740
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.950 AC: 1389338AN: 1461776Hom.: 660865 Cov.: 65 AF XY: 0.952 AC XY: 692158AN XY: 727184 show subpopulations
GnomAD4 exome
AF:
AC:
1389338
AN:
1461776
Hom.:
Cov.:
65
AF XY:
AC XY:
692158
AN XY:
727184
show subpopulations
African (AFR)
AF:
AC:
28911
AN:
33480
American (AMR)
AF:
AC:
38536
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
AC:
23979
AN:
26136
East Asian (EAS)
AF:
AC:
34645
AN:
39700
South Asian (SAS)
AF:
AC:
83716
AN:
86258
European-Finnish (FIN)
AF:
AC:
50140
AN:
53328
Middle Eastern (MID)
AF:
AC:
5457
AN:
5768
European-Non Finnish (NFE)
AF:
AC:
1067114
AN:
1111992
Other (OTH)
AF:
AC:
56840
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
4569
9138
13708
18277
22846
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
21620
43240
64860
86480
108100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.920 AC: 140073AN: 152216Hom.: 64584 Cov.: 32 AF XY: 0.919 AC XY: 68413AN XY: 74432 show subpopulations
GnomAD4 genome
AF:
AC:
140073
AN:
152216
Hom.:
Cov.:
32
AF XY:
AC XY:
68413
AN XY:
74432
show subpopulations
African (AFR)
AF:
AC:
36159
AN:
41522
American (AMR)
AF:
AC:
13253
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
AC:
3169
AN:
3472
East Asian (EAS)
AF:
AC:
4440
AN:
5150
South Asian (SAS)
AF:
AC:
4657
AN:
4832
European-Finnish (FIN)
AF:
AC:
9955
AN:
10616
Middle Eastern (MID)
AF:
AC:
279
AN:
294
European-Non Finnish (NFE)
AF:
AC:
65323
AN:
68012
Other (OTH)
AF:
AC:
1930
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
566
1132
1698
2264
2830
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
908
1816
2724
3632
4540
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3191
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
Nov 24, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Isolated microphthalmia 6 Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Retinal degeneration Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Isolated microphthalmia 5 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.